Area of research
Oncology · Cancer Research
Research interest
Research interests include Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Breast Lesions and Carcinomas, and Pharmacovigilance and Adverse Drug Reactions.
The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment that Drives Tumor Radioresistance.
A Magnification Alignment Framework Enables Computation- and Communication-Efficient Computational Pathology.
BRIGHT: A Collaborative Generalist-Specialist Foundation Model for Breast Pathology
Breast Carcinomas Resembling Acinic Cell Carcinoma: Comprehensive Analysis of 14 Cases and Review of the Literature.
Inhibition of ATM enhances the immunogenicity of triple-negative breast cancer by promoting MHC-I expression.
Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer
Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses
Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast Cancer
Effects of S-Adenosylmethionine on Cognition in Animals and Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterations
Untargeted Metabolomics of Feces Reveals Diagnostic and Prognostic Biomarkers for Active Tuberculosis and Latent Tuberculosis Infection: Potential Application for Precise and Non-Invasive Identification
Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study
Instant diagnosis of gastroscopic biopsy via deep-learned single-shot femtosecond stimulated Raman histology
Blood levels of circulating methionine components in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
STAT3 and PD-L1 are negatively correlated with ATM and have impact on the prognosis of triple-negative breast cancer patients with low ATM expression.
Effects of low tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer
STAT3 And PD-L1 Are Negatively Regulated By ATM And Impact On The Prognosis Of Triple Negative Breast Cancer Patients With Low ATM Expression
Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer.
ATM kinase regulates tumor immunoreactions in lymphocyte-predominant breast cancer through modulation of NKG2D ligand and TNF cytokines on tumor cells.
Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
Green tea polyphenols reduce obesity in high‐fat diet‐induced mice by modulating intestinal microbiota composition
OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma
Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications
ATM-mediated Mad1 Serine 214 phosphorylation regulates Mad1 dimerization and the spindle assembly checkpoint
High Capacity Nanoporous Silicon Carrier for Systemic Delivery of Gene Silencing Therapeutics
Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery
Multistage Vectored siRNA Targeting Ataxia‐Telangiectasia Mutated for Breast Cancer Therapy
Activation of the ATM-Snail pathway promotes breast cancer metastasis